We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Matt Brauer joined Third Rock from Genentech, where he was a senior scientist and director of data science, and where he co-led Roche’s clinical genetics program. In that role he was responsible for managing, processing and analyzing large and complex genomics datasets from across the global organization. He also led the effort to develop and deploy analytic tools that would allow R&D scientists to more rapidly and effectively explore their own data.
Prior to Genentech Matt worked with David Botstein at Stanford and as a research fellow at Princeton’s Lewis-Sigler Institute for Integrative Genomics. In these positions he applied new technologies for understanding the genetics of metabolic pathways in yeast.
Matt is currently helping to build and launch the data science group of a new TRV company that will develop therapeutics based on insights derived from genetic modifier studies.
This speaker's sessions: